Chronic myeloid leukemia (CML) is a myeloproliferative tumor originating from hematopoietic stem cells, characterized by the formation of the BCR-ABL1 fusion gene [1]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.